Lido Advisors, LLC Moderna, Inc. Transaction History

Lido Advisors, LLC

$16.8 Billion
Q1 2024

A detailed history of Lido Advisors, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Lido Advisors, LLC holds 82,135 shares of MRNA stock, worth $9.52 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

82,135

Previous 81,288 1.04%

Holding current value

$9.52 Million

Previous $8.08 Million 8.26%

% of portfolio

0.05%

Previous 0.05%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$85.37 - $115.44 $72,308 - $97,777	847 Added 1.04%	82,135 $8.75 Million
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $5.33 Million - $8 Million	76,651 Added 1653.03%	81,288 $8.08 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $5,302 - $6,963	55 Added 1.2%	4,637 $478,000
Q2 2023 Aug 09, 2023	SELL	$118.5 - $160.53 $1.36 Million - $1.85 Million	-11,499 Reduced 71.51%	4,582 $556,000
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $1.79 Million - $2.6 Million	13,222 Added 462.47%	16,081 $2.47 Million

Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $53,271 - $94,518	-450 Reduced 13.6%	2,859 $513,000
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $131,529 - $216,316	-1,114 Reduced 25.19%	3,309 $391,000
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $1,756 - $2,648	-15 Reduced 0.34%	4,423 $631,000
Q1 2022 May 17, 2022	BUY	$126.46 - $235.05 $150,108 - $279,004	1,187 Added 36.51%	4,438 $764,000
Q4 2021 Feb 15, 2022	BUY	$225.82 - $368.51 $89,876 - $146,666	398 Added 13.95%	3,251 $825,000
Q3 2021 Feb 15, 2022	BUY	$221.9 - $484.47 $17,752 - $38,757	80 Added 2.88%	2,853 $1.1 Million
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $255,406 - $557,624	1,151 Added 70.96%	2,773 $1.07 Million
Q2 2021 Aug 12, 2021	BUY	$129.91 - $234.98 $210,714 - $381,137	1,622 New	1,622 $381,000

Others Institutions Holding MRNA

# of Institutions

1,038

Shares Held

245M

Call Options Held

12.1M

Put Options Held

9.36M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $45.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lido Advisors, LLC with notifications on news.

Account

Lido Advisors, LLC Moderna, Inc. Transaction History